R. Mohan et al., Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers, INT J RAD O, 46(3), 2000, pp. 619-630
Citations number
13
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Purpose: The dose distributions of intensity-modulated radiotherapy (IMRT)
treatment plans can be shown to be significantly superior in terms of highe
r conformality if designed to simultaneously deliver high dose to the prima
ry disease and lower dose to the subclinical disease or electively treated
regions. We use the term "simultaneous integrated boost" (SIB) to define su
ch a treatment. The purpose of this paper is to develop suitable fractionat
ion strategies based on radiobiological principles for clinical trials and
routine use of IMRT of head and neck (HN) cancers. The fractionation strate
gies are intended to allow escalation of tumor dose while adequately sparin
g normal tissues outside the target volume and considering the tolerances o
f normal tissues embedded within the primary target volume.
Methods and Materials: IMRT fractionation regimens are specified in terms o
f "normalized total dose" (NTD), i.e.,the biologically equivalent dose give
n in 2 Gy/fx. A linear-quadratic isoeffect formula is applied to convert NT
Ds into "nominal" prescription doses. Nominal prescription doses for a high
dose to the primary disease, an intermediate dose to regional microscopic
disease, and lower dose to electively treated nodes are used for optimizing
IMRT plans. The resulting nominal dose distributions are converted back in
to NTD distributions for the evaluation of treatment plans. Similar calcula
tions for critical normal tissues are also performed. Methods developed wer
e applied for the intercomparison of several HN treatment regimens, includi
ng conventional regimens used currently and in the past, as well as SIE str
ategies, This was accomplished by comparing the biologically equivalent NTD
values for the gross tumor and regional disease, and bone, muscle, and muc
osa embedded in the gross tumor volume.
Results: (1) A schematic HN example was used to demonstrate that dose distr
ibutions for SIB IMRT are more conformal compared to dose distributions whe
n IMRT is divided into a large-field phase and a boost phase, Both were sho
wn to be significantly superior compared to dose distributions obtained usi
ng conventional beams for the large-field phase followed by IMRT for the bo
ost phase, (2) The relationship between NTD and nominal dose for HN tumors
was found to be quite sensitive to the choice of tumor clonogen doubling ti
me but relatively insensitive to other parameters. (3) For late effect norm
al tissues embedded in the tumor volume and assumed to receive the same dos
e as the tumor, the biologically equivalent NTD for the SIE IMRT may be sig
nificantly higher. (4) Normal tissues outside the target volume receive low
er dose due to the higher conformality of the IMRT plans, The biologically
equivalent NTDs are even lower due to the lower dose per fraction in the SI
E strategy.
Conclusions: IMRT dose distributions are most conformal when designed to be
delivered as SIE. Using isoeffect radiobiological relationships and publis
hed HN data, fractionation strategies can be designed in which the nominal
dose levels to the primary, regional disease and electively treated volumes
are appropriately adjusted, each receiving different dose/fx, Normal tissu
es outside the treated volumes are at reduced risk in such strategies since
they receive lower total dose as well as lower dose/fx. However, the late
effect toxicities of tissues embedded within the primary target volume and
assumed to receive the same dose as the primary may pose a problem. The eff
icacy and safety of the proposed fractionation strategies mill need to be e
valuated with careful clinical trials, (C) 2000 Elsevier Science Inc.